| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $737.2M | +10.9% | +18.9% |
| Cost of Revenue | $330.9M | +10.8% | +19.6% |
| Gross Profit | $406.2M | +11.0% | +18.3% |
| R&D Expense | $98.2M | +2.0% | +15.4% |
| SG&A Expense | $112.9M | +7.5% | +19.6% |
| Operating Income | $195.2M | +18.5% | +19.0% |
| Pre-tax Income | $205.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.08B | +37.3% | +54.4% |
| Short-term Investments | $188.2M | -47.5% | -75.3% |
| Accounts Receivable | $241.6M | +24.0% | +46.7% |
| Inventory | $505.7M | +3.1% | +19.0% |
| Current Assets | $2.11B | +10.1% | -2.2% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $733.3M | — | — |
| Capital Expenditures | $131.0M | — | — |
| Investing Cash Flow | -$145.7M | — | — |
| Financing Cash Flow | -$208.6M | — | — |
| Free Cash Flow | $602.3M | — | — |
| +16.2% |
| +17.9% |
| Income Tax | $27.3M | -36.9% | -8.6% |
| Net Income | $178.3M | +33.3% | +23.4% |
| EPS (Basic) | $3.72 | +33.3% | +25.7% |
| EPS (Diluted) | $3.71 | +33.5% | +25.8% |
| $4.21B |
| +5.9% |
| +47.3% |
| Current Liabilities | $442.8M | +15.5% | +31.6% |
| Total Liabilities | $638.4M | +12.0% | +26.9% |
| Stockholders' Equity | $3.57B | +4.9% | +51.7% |